These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11172593)

  • 21. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding.
    Fuchs B; Hecker D; Scheidtmann KH
    Eur J Biochem; 1995 Mar; 228(3):625-39. PubMed ID: 7737156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
    Bargonetti J; Reynisdóttir I; Friedman PN; Prives C
    Genes Dev; 1992 Oct; 6(10):1886-98. PubMed ID: 1398068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells.
    Kao C; Huang J; Wu SQ; Hauser P; Reznikoff CA
    Carcinogenesis; 1993 Nov; 14(11):2297-302. PubMed ID: 8242858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial transformation of human tumor cell lines showing defective interaction between unusual p53 gene product and SV40 large-T antigen.
    Van Roy F; Liebaut G; Mareel M; Fiers W
    Oncogene; 1990 Feb; 5(2):207-18. PubMed ID: 2157184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers.
    Carbone M; Rudzinski J; Bocchetta M
    Virology; 2003 Oct; 315(2):409-14. PubMed ID: 14585344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.
    Herzig M; Novatchkova M; Christofori G
    Biol Chem; 1999 Feb; 380(2):203-11. PubMed ID: 10195427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and DNA polymerase alpha compete for binding to SV40 T antigen.
    Gannon JV; Lane DP
    Nature; 1987 Oct 1-7; 329(6138):456-8. PubMed ID: 3309672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.
    Friedman PN; Kern SE; Vogelstein B; Prives C
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9275-9. PubMed ID: 2174557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system.
    Li B; Fields S
    FASEB J; 1993 Jul; 7(10):957-63. PubMed ID: 8344494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse p53 inhibits SV40 origin-dependent DNA replication.
    Braithwaite AW; Sturzbecher HW; Addison C; Palmer C; Rudge K; Jenkins JR
    Nature; 1987 Oct 1-7; 329(6138):458-60. PubMed ID: 2821401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.
    Pietruska JR; Kane AB
    Cancer Res; 2007 Apr; 67(8):3637-45. PubMed ID: 17440075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.
    Henning W; Rohaly G; Kolzau T; Knippschild U; Maacke H; Deppert W
    J Virol; 1997 Oct; 71(10):7609-18. PubMed ID: 9311842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression.
    Drayman N; Ben-Nun-Shaul O; Butin-Israeli V; Srivastava R; Rubinstein AM; Mock CS; Elyada E; Ben-Neriah Y; Lahav G; Oppenheim A
    Oncotarget; 2016 Aug; 7(33):52643-52660. PubMed ID: 27462916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian virus 40 large T antigen and two independent T-antigen segments sensitize cells to apoptosis following genotoxic damage.
    Cole SL; Tevethia MJ
    J Virol; 2002 Aug; 76(16):8420-32. PubMed ID: 12134045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation.
    Deppert W; Steinmayer T; Richter W
    Oncogene; 1989 Sep; 4(9):1103-10. PubMed ID: 2674854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53.
    Kraus E; Strong LC; Tainsky MA
    Gene; 1998 May; 211(2):229-34. PubMed ID: 9602136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts.
    Lenahan MK; Ozer HL
    Oncogene; 1996 May; 12(9):1847-54. PubMed ID: 8649844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts.
    Goldberg YP; Leaner VD; Parker MI
    J Cell Biochem; 1992 May; 49(1):74-81. PubMed ID: 1322917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.